Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • IHH Healthcare,...

    IHH Healthcare, Temasek looking to acquire majority stake in Medanta: Report

    Written by Ruby Khatun Khatun Published On 2018-02-07T16:48:24+05:30  |  Updated On 7 Feb 2018 4:48 PM IST
    IHH Healthcare, Temasek looking to acquire majority stake in Medanta: Report

    New Delhi: IHH Healthcare Behard and Temasek Holding seem to be in the race to acquire a controlling stake in Medanta hospital recent media reports have revealed.


    According to a recent report in TOI, both the firms are in separate talks with Medanta hospitals for a deal, which is likely to be valued around Rs 5,800 crore ($900 million)


    IHH Healthcare, one of the largest healthcare group which operates more than 50 hospitals in 10 markets under brands like Gleneagles, Mount Elizabeth and Parkway was recently rumoured to have been in talks for acquiring major stake in Fortis. However, the deal did not go through and the giant is eager to partner with Trehan


    According to the TOI report, IHH is trying to acquire Medanta shares held by Carlyle, Temasek and the founding partners of Trehan, which would amount to a majority stake in the healthcare firm.Presently, private equity major Carlyle holds 27 percent stake and Temasek holds 18 percent stake in Medanta hospital together constituting 45 percent stake, whereas the remaining 55 percent is with Trehan’s family and other promoters, including co-founder Sunil Sachdeva.


    On the other hand, Temasek has also shown their interest in buying out investors who are in exit mode and also keen on acquiring a large private healthcare services provider in Asia’s third-largest economy.In 2015, Temasek had purchased shares held by one of the founding shareholders Punj Lloyd in $105 million, valuing Medanta at about $600 million.


    Temasek also owns minority shares in Manipal Hospitals and cancer care specialist HCG.


    Medanta hospital was founded in 2009 by renowned cardiovascular surgeon Naresh Tehran and Sunil Sachdeva, operates more than 1,600 beds, mostly from its large Gurgaon facility spread over 43 acres.


    Besides a few shareholders seeking an exit, the company is also looking for infusion of fresh capital to expand footprint in newer markets such as Lucknow, Indore and Ranchi.


    IHH was also eyeing a deal with Max Healthcare, in which South African partner Life Care is selling 50% ownership.


    TOI reports the domestic healthcare industry is projected to grow at a compounded annual growth rate of 12%, hitting Rs 6.85 lakh crore by 2020, on the back of rising insurance coverage, greater awareness and changing disease patterns.

    acquireBain CapitalcancerCarlyleCarlyle GroupFortis HealthcareHCGIHH HealthcareIHH Healthcare BerhadKKRMajority stakeManipal HospitalsMax HealthcareMedantaMedanta HospitalTemasekTemasek HoldingTPG
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok